Clinical Trials Directory

Trials / Completed

CompletedNCT00335452

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
25,086 (actual)
Sponsor
Sanofi · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate whether a higher dosage of clopidogrel with aspirin (two doses) will decrease the risk of ischemic complications (cardiac death (CV death), myocardial infarction (MI), stroke) after a percutaneous coronary intervention (PCI).

Conditions

Interventions

TypeNameDescription
DRUGClopidogreloral administration
DRUGacetylsalicyclic acid (ASA)oral administration

Timeline

Start date
2006-06-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2006-06-09
Last updated
2010-11-18
Results posted
2010-10-07

Locations

38 sites across 38 countries: United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, Estonia, Finland, France, Germany, Greece, India, Ireland, Israel, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Romania, Russia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey (Türkiye), United Kingdom

Source: ClinicalTrials.gov record NCT00335452. Inclusion in this directory is not an endorsement.